Viridian Therapeutics, Inc.
USD18.79
+0.89 (+4.97%)
CEO
Stephen F. Mahoney
IPO Date
2014-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.37
Prev. Close
$17.90
Day Low
$18.24
Day High
$19.53
52W Low
$13.18
52W High
$34.29
Market Cap
$1.69B
Volume
7.59M
| -4.8 |
| 31 Dec 2023 | FY | 100.0% | -75711.5% | -53.8% | -48.5% | 0.05 | 18.26 | -4.1 |
| 31 Dec 2022 | FY | 100.0% | -7329.2% | -32.9% | -29.8% | 0.01 | 12.73 | -7.2 |
| 31 Dec 2021 | FY | 100.0% | -2680.2% | -42.3% | -39.0% | 0.00 | 14.68 | -3.0 |
| 31 Dec 2020 | FY | -2595.6% | -10544.3% | -92.2% | -84.4% | 0.00 | 12.14 | -0.5 |
| 31 Dec 2019 | FY | 100.0% | -938.6% | -265.8% | -138.4% | 0.53 | 2.92 | -0.4 |
| 31 Dec 2018 | FY | -262.8% | -390.0% | -63.7% | -49.4% | 0.20 | 9.71 | -2.7 |
| 31 Dec 2017 | FY | -390.2% | -662.3% | -68.8% | -50.5% | 0.26 | 13.31 | -7.6 |
| 31 Dec 2016 | FY | 23.6% | -379.8% | 3887.7% | -297.6% | -3.21 | 0.93 | -4.3 |
| -5.5 |
| 30 Sept 2025 | Q3 | 100.0% | -49.0% | -6.9% | -6.0% | 0.05 | 11.28 | -12.8 |
| 30 Jun 2025 | Q2 | 100.0% | -134313.3% | -19.6% | -17.3% | 0.04 | 11.01 | -2.8 |
| 31 Mar 2025 | Q1 | 100.0% | -120711.1% | -14.4% | -13.1% | 0.04 | 19.49 | -3.2 |
| 31 Dec 2024 | Q4 | 100.0% | -110729.2% | -11.9% | -10.7% | 0.03 | 15.43 | -4.8 |
| 30 Sept 2024 | Q3 | 100.0% | -89173.3% | -10.8% | -9.9% | 0.03 | 18.55 | -4.9 |
| 30 Jun 2024 | Q2 | 100.0% | -90268.1% | -12.3% | -11.1% | 0.04 | 15.82 | -3.2 |
| 31 Mar 2024 | Q1 | 100.0% | -67419.4% | -8.3% | -7.7% | 0.04 | 23.99 | -5.4 |
| 31 Dec 2023 | Q4 | 100.0% | -92861.1% | -15.1% | -13.6% | 0.05 | 18.26 | -4.0 |